Carregant...
Complete remission of critical neurohistiocytosis by vemurafenib
OBJECTIVE: To describe a patient with life-threatening brainstem neurohistiocytosis who recovered completely upon targeted treatment with the V600E mutation-specific BRAF inhibitor vemurafenib. METHODS: We report clinical, histiologic, genetic, and sequential imaging findings, including fluorodeoxyg...
Guardat en:
Publicat a: | Neurol Neuroimmunol Neuroinflamm |
---|---|
Autors principals: | , , , , , |
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
Lippincott Williams & Wilkins
2015
|
Matèries: | |
Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4345630/ https://ncbi.nlm.nih.gov/pubmed/25745636 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000078 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|